Despite widely held views suggesting that phytoplankton could take a century to adapt to climate change, direct measurements indicate that they are perhaps 10 times faster when reacting to changes in sea temperatures and incident light, according to Andrew Irwin of Mount Allison University in Sackville, New Brunswick, Canada, and his collaborators there and in the United States and Venezuela. Thus, they note, climate change modelers should consider revising their projections because such biological communities likely could respond to what happens around them far faster than anticipated. Details appeared 5 May 2015 in Proceedings of the National Academy of Sciences (doi:10.1073/ pnas.1414752112) . "I'm not sure if the temperature adaptation was particularly unexpected," Irwin says. "But many researchers have been acting as though phytoplankton won't adapt quickly-over a few years to a decade-to changes in temperature. "However, it seems likely that climate change will affect many phytoplankton species in two ways," he continues. "First, the environments in which each species is found may change. Second, large-scale changes in temperature, ocean circulation, and the distribution of resources necessary for phytoplankton to grow will alter the rates and distribution of primary production." Thus, he and his collaborators conclude, "Community ecosystem models can no longer assume that phytoplankton cannot adapt."
"The authors are, to my knowledge, the fırst to present evidence for decadal-scale evolutionary adaptation of phytoplankton in a natural marine community," says S. Lan Smith of the Japan Agency for Marine-Earth Science and Technology in Yokohama. "However, given the genetic variability within species and the constant transport of plankton in the ocean, the local changes they infer in niches could also have resulted from immigration of phytoplankton . . . Nevertheless, given the great numbers and short generation times of phytoplankton, and independent evidence of rapid adaptation from laboratory experiments, I agree with the authors [about] modeling studies."
"The results of this work will come as no surprise to many biologists; organisms adapt over time to counter changes in their environment," says Kevin White of Swansea University in Wales, United Kingdom. "However, critically, this paper may jolt many ecosystem modelers to reappraise their models. [Irwin's] results hopefully will catalyze [that] much-needed review." "I do not think anyone in the community that works on phytoplankton physiology would have been at all surprised by these results," adds Jack A. Gilbert from Argonne National Laboratory, affıliated with the University of Chicago in Illinois. "This is an interesting longitudinal time series, [but] the impact of these fındings will be extremely minimal, which [Irwin and his collaborators] fully admit."
Barry E. DiGregorio is a freelance writer in Middleport, N.Y.
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Recent national and international developments involving microbiology and related science policy matters include:
• Reflecting a continuing concern over antibiotic resistance issues, the Obama administration in June invited representatives from more than 150 food companies, retailers, and human and animal health stakeholders to a "White House Forum on Antibiotic Stewardship." The President also signed a memorandum directing federal departments and agencies to create "a preference for meat and poultry produced according to responsible antibiotic use." • In a related development, officials of the Food and Drug Administration plan to expand data collection on the use of antibiotics in agriculture.
• Further, the National Institutes of Health and the Biomedical Advanced
Research and Development Authority in June announced a competition in which up to $20 million could be made available for the delivery of one or more successful rapid point-of-care diagnostics that may be used by health care providers to identify bacterial infections. By the late 1940s, the fırst of several vaccines to protect against pertussis came into wide use. In this case, the vaccine derived from whole cells of Bordetella pertussis, the bacterial pathogen responsible for this disease, also known as whooping cough because of the characteristic and often long-lasting coughing spasms that afflict infected individuals. Although highly effective, the whole-cell (WC) vaccine tends to cause side effects, and its use was phased out in the United States (and a bit later in other countries) after 1991 when acellular, or component-antigen, pertussis vaccines became available.
Not long thereafter, public health offıcials began to see a rise in incidence of pertussis, according to Tondella. That rise was subtle at fırst, and nowhere near what occurred before pertussis vaccines were available. Some of the rise can be attributed to surveillance bias and improved diagnostic procedures, and other portions to outright refusal by parents in some segments of the population to allow their children to be vaccinated. California, for example, is "experiencing a pertussis epidemic" that is driven largely by such refusals, according to public health offıcials at CDC and in California. Another factor is "waning immunity" among those who receive the acellular vaccine, which depends on repeated boosting to remain effectiveand, even then, affords less than full coverage but at least protects against the most severe forms of this disease.
During this same period, pertactindefıcient strains of B. pertussis began to emerge, according to Tondella. The adhesin molecule pertactin is considered one of several major virulence factors. Several different types of mutation give rise to these strains, and their prevalences vary geographically, she says. "Vaccinated patients had higher odds of having pertactin-defıcient mutants, [which was] the fırst evidence of a selective advantage."
CDC and other investigators, who are analyzing the genomes from several hundred isolates obtained from pertussis patients in California and other states during recent outbreaks, fınd rearrangements among other changes, she adds. "We don't know what this means in terms of phenotype. But we will need to take these molecular and genomic changes into account to develop better vaccines."
"The whole-cell pertussis vaccine is still used in much of the world," says Jason Warfel of the Food and Drug Administration (FDA) in Silver Spring, Md., who spoke during the same symposium. Although "all the vaccines are equivalent in terms of preventing severe pertussis," he adds, WC vaccines apparently "do a better job at preventing nasopharyngeal colonization and clearing the disease faster than the acellular vaccines. We need to identify the breadth of essential antigens playing important roles in the WC vaccines." However, because the newer, acellular vaccines are thought to cause fewer side effects than the WC vaccines, the United States is unlikely to go back to using them, he points out.
Jeffrey L. Fox is the Microbe Current Topics and Features Editor.
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In Leaving Africa Centuries ago, Green Monkeys Lost Viruses David C. Holzman
After African green monkeys (AGMs) were shipped to the Caribbean during the 17th century-a species introduction that stemmed from the slave trade-two of three blood-borne viruses that these animals carried were lost from this transplanted primate population, according to Eric Delwart of the Blood Systems Research Institute in San Francisco and his collaborators.
